• JUser: :_load: Unable to load user with ID: 78
ASM Policy efforts focus on communicating the importance of the microbial science to Congress, Federal Agencies and the Public.

The ASM signed onto a letter as a member of the Informal Coalition on Biodefense and Public Health Preparedness  urging increased funding in FY 2018 for programs that support emergency preparedness.

Friday, 09 June 2017 10:31

Public Policy Brief - June 9, 2017

The ASM has released a statement on President’s announcement that the United States will be withdrawing from the Paris Climate Agreement.   The statement stresses the importance of scientific studies to understand global climate change since it influences everything, from the production of food, the quality of our air and water, to the spread of infectious diseases and the occurrence and prevalence of pathogenic microorganisms, vectors and disease outcomes.

Tuesday, 30 May 2017 10:26

Clinical Microbiology Issues Update - May 2017

Posted by:

The May issue of the Clinical Microbiology Issues Update has been published by the Office of Public Affairs.

Friday, 26 May 2017 09:59

Public Policy Brief - May 26, 2017

The ASM Office of Public Affairs has completed a summary of the Administration's FY 2018 budget proposal with programs and agencies of importance to the microbial sciences.

The ASM signed onto a coalition letter to Congressional leadership urging support for scientific research as they begin work on the FY 2018 appropriations.

ASM Letter regarding the nomination of the Undersecretary for Research, Education and Economics at the U.S. Department of Agriculture

The ASM has released a statement on the release of the Administration’s FY 2018 Budget urging Congress to reject the Administration’s proposed severe cuts to science and public health programs.  

The ASM submitted comments in response to the Department of State's emergency review on supplemental questions for high risk Visa applicants. 

The May issue of the Minority Microbiology Mentor Newsletter has been published by the Committee on Microbiological Issues Impacting Minorities.

The ASM sent a letter to all members of Congress thanking them for their efforts to increase funding for the National Institutes of Health, the Centers for Disease Control and Prevention, the US Department of Agriculture and the Department of Energy Office of Science and the Food and Drug Administration in the FY 2017 Omnibus Spending Bill.

The ASM signed onto a letter sent to House and Senate appropriations committee leaders calling on Congress to increase the fiscal 2018 302(b) subcommittee allocations for Labor-HHS.

ASM joined the Infectious Diseases Society of America (IDSA) and the Pan American Society for Clinical Virology (PASCV) in drafting comments for the draft Diagnostic Accuracy and Innovation Act (DAIA) legislation.  The DAIA builds upon previous efforts to establish a new framework for the regulation of both in vitro diagnostic tests and laboratory-developed tests (LDTs).

The ASM has compiled its funding recommendations on biomedical and life science research and public health for fiscal year 2018 in a booklet. It includes the statements sent to Congress on the federal agencies that support microbial sciences research. 

Monday, 01 May 2017 09:44

Public Policy Brief - May 1, 2017

Thursday, 13 April 2017 12:17

Public Policy Brief - April 13, 2017

The ASM submitted funding recommendations for the Department of Defense for FY 2018 to Congress.

Page 4 of 6